EyeGate Pharmaceuticals, Inc.

EyeGate Pharmaceuticals, Inc.

EyeGate Pharmaceuticals, Inc.

EyeGate Pharmaceuticals develops medicines to treat eye diseases using its non-invasive, iontophoretic drug-delivery system.
Founded
1998
Raised
$3.8M
Follow us
Alexa global traffic share
Latest funding
$3,770,000
Post-IPO debt - 2016
Team Size
2
Employees
Xconomy

EyeGate Deals Treatment Rights to Valeant to Pay for Clinical Trials

Health